Literature DB >> 12705556

Surgery and local treatments of liver metastases from colorectal cancer: how to improve results.

C Penna1, B Nordlinger.   

Abstract

Over the last 30 years, the benefits of surgical resection for liver metastases have been established. Actually, surgical resections are feasible with a very low mortality and a 5-year survival that approaches 40 %. However, even if progresses in surgery and anaesthesiology now render possible extensive resections with removal of large, numerous or bilateral lesions, only 10 to 20 % of patients are candidate to surgery. The others gain benefit from chemotherapy with more and more active drugs. To improve this overall picture, efforts have been made to increase the number of patients that could be candidates for surgery. Shrinkage of tumours after administration of preoperative chemotherapy and availability of ablative techniques now permit to treat with curative intent metastases initially considered as non-resectable.

Entities:  

Mesh:

Year:  2003        PMID: 12705556     DOI: 10.1177/145749690309200113

Source DB:  PubMed          Journal:  Scand J Surg        ISSN: 1457-4969            Impact factor:   2.360


  3 in total

Review 1.  Benefit-risk assessment of irinotecan in advanced colorectal cancer.

Authors:  Bengt Glimelius
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  New insights into syndecan-2 expression and tumourigenic activity in colon carcinoma cells.

Authors:  Innoc Han; Haein Park; Eok-Soo Oh
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

3.  Health economic evaluation of ferucarbotran-enhanced MRI in the diagnosis of liver metastases in colorectal cancer patients.

Authors:  Lieven Annemans; Riccardo Lencioni; Hans Warie; Carlo Bartolozzi; Marco Ciceri; Ulrike Müller
Journal:  Int J Colorectal Dis       Date:  2007-10-02       Impact factor: 2.571

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.